American Regent Launches a New Vial Presentation
/PRNewswire/ -- American Regent, Inc. and Provepharm Life Solutions are pleased to announce the availability of ProvayBlue® (methylene blue) Injection, USP in...
Source: prnewswire.com
📰 Concomitant Use News
Page 3 - Concomitant Use News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Concomitant Use. Real-time updates on events, politics, business and more.
New analyses of Mounjaro™ (tirzepatide) injection for the treatment of adults with type 2 diabetes presented at the American Diabetes Association's® 82nd Scientific Sessions®
Mounjaro led to significantly greater fat mass reductions compared to placebo and to injectable semaglutide 1 mg in adults with type 2 diabetes in...
Source: businessinsider.com
Lilly's SURMOUNT-1 results published in The New England Journal of Medicine show tirzepatide achieved between 16.0% and 22.5% weight loss in adults with obesity or overweight
/PRNewswire/ -- Detailed results from Eli Lilly and Companys (NYSE: LLY) phase 3 SURMOUNT-1 clinical trial evaluating tirzepatide for the treatment of obesity...
Source: prnewswire.com
Lilly's SURMOUNT-1 results published in The New England Journal of Medicine show tirzepatide achieved between 16.0% and 22.5% weight loss in adults with obesity or overweight - Press Release
Detailed results from Lilly's first phase 3 trial in obesity or overweight presented at the American Diabetes Association's® 82nd Scientific Sessions®
Source: wiredprnews.com
U.S. Food and Drug Administration Approves Orencia (abatacept) in Combination with a Calcineurin Inhibitor and Methotrexate for the Prevention of Acute Graft Versus Host Disease (aGvHD)...
15.12.2021 - Bristol Myers Squibb (NYSE:BMY): U.S. Food and Drug Administration Approves Orencia (abatacept) in Combination with a Calcineurin Inhibitor and Methotrexate for the Prevention of Acute Graft Versus Host Disease (aGvHD) in Patients Undergoing ...
Source: wallstreet-online.de
UCB to present new data at the American Epilepsy Society 75th Annual Meeting 2021, reinforcing long-standing commitment to advancing epilepsy treatment and care
/PRNewswire/ -- 1:30 p.m. ET: UCB today announced that new data from its seizure treatment portfolio (BRIVIACT, NAYZILAM, and VIMPAT) will be showcased at the...
Source: prnewswire.com
UCB to present new data at the American Epilepsy Society 75th Annual Meeting 2021, reinforcing long-standing commitment to advancing epilepsy treatment and care
/PRNewswire/ -- 1:30 p.m. ET: UCB today announced that new data from its seizure treatment portfolio (BRIVIACT, NAYZILAM, and VIMPAT) will be showcased at the...
Source: prnewswire.com
ADMA Biologics Announces Data Presented at the 2021 ISIRV-WHO Conference
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Combining two medications doubles gout treatment success, study reveals
Combining two medications doubles gout treatment success, study reveals By combining two medications, researchers at Michigan Medicine optimized a therapy for people with gout, a condition that causes severe damage and disability if left untreated. The study revealed how a second drug taken orally more than doubled the effectiveness of Pegloticase, an intravenous gout treatment used to dissolve crystalized uric acid in the joints when oral medications fail. Gout is a challenging disease to trea...
United States Mycophenolate Mofetil Emily Henderson Michigan Medicine Reducing Immunogenicity Concomitant Use
Source: news-medical.net
Gout treatment success doubled by combining two drugs, study finds
Credit: Michigan Medicine - Jacob Dwyer By combining two medications, researchers at Michigan Medicine optimized a therapy for people with gout, a condition that causes severe damage and disability if left untreated. The study revealed how a second drug taken orally more than doubled the effectiveness of Pegloticase, an intravenous gout treatment used to dissolve crystalized uric acid in the joints when oral medications fail. "Gout is a challenging disease to treat because there are only a han...
United States Mycophenolate Mofetil National Institute Of Arthritis Horizon Therapeutics Michigan Medicine Puja Khanna
Source: eurekalert.org